3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Ovarian Neoplasms
1
Multiple Myeloma
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumors
1
Interventions
Injections
18
Carboplatin
14
Docetaxel
11
pembrolizumab
8
durvalumab
7
Cisplatin
6
linifanib
5
Paclitaxel
5
Nivolumab
5
zimberelimab
4
talazoparib
4
olaparib
4
Panobinostat
4
Itraconazole
4
Bevacizumab
4
tremelimumab
3
sintilimab
3
depatuxizumab
3
atezolizumab
3
ST 1481
3
S 1 (combination)
3
Rifampin
3
Pemetrexed
3
Oxaliplatin
3
Fluorouracil
3
Everolimus
3
Drug Therapy
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Advanced Solid Tumors
×
Maximum Tolerated Dose
×
Clear all
NCT02994953
2024-09-20
COMBO
EMD Serono
Phase 1
Terminated
52 enrolled
34 charts